Clinical trial on the efficacy of the N-methyl glucamine associated to immunotherapy in dogs, experimentally infected with Leishmania (Leishmania) chagasi

Revue de Medecine Veterinaire

Volumn 153, Issue 2, 2002, Pages 75-84

  Melo, M A ^a   Franca Silva J C ^a   Azevedo, E O ^a   Tabosa, I M ^a   Da Costa, R T ^a   Da Costa, C A ^a   Costa, J O ^a   Mayrink, W ^a   Genaro, O ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Canine visceral leishmaniasis; Immunotherapy; Leishmania chagasi; N methyl glucamine; Treatment

Indexed keywords

LEISHMANIA VACCINE; MEGLUMINE ANTIMONATE; PROTOZOON ANTIBODY;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOPSY; BONE MARROW; CELLULAR IMMUNITY; CONTROLLED STUDY; DOG; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; IMMUNOTHERAPY; INOCULATION; LEISHMANIA BRAZILIENSIS; LEISHMANIA CHAGASI; MALE; NONHUMAN; PARASITE LOCALIZATION; PARASITE SERODIAGNOSIS; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

EID: 0036462544     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Tratamiento de la leishmaniosis canina. Parte 1
2. A cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis
3. TRALd = A rapid test specific for serodiagnosis of visceral leishmaniasis
4. Disposition of antimony and aminosidine in dogs after administration separately and together; implications for therapy of leishmaniasis
5. Iron status and anemia in canine leishmaniasis
6. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis
7. Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs
8. Cross-reactivity in fluorescence tests for Trypanosoma and Leishmania antibodies
9. Estudo comparativo entre meios de cultura para isolamento de leishmanias
10. Recent advances in the treatment of visceral leishmaniasis
11. Visceral leishmaniasis in Brasil. Geographical distribution and transmission
12. Serological diagnosis and treatment of canine leishmaniasis
13. Visceral leishmaniasis
14. Naturally occuring visceral leishmaniasis in dogs : Clinical aspects
15. Ocorrência de calazar em área urbana da grande Belo Horizonte, MG
16. The course of experimental visceral leishmaniasis in dogs
17. Montenegro skin test in dogs experimentally infected with Leishmania (Viannia) braziliensis
18. Evaluation of an immunochromatographic assay for the diagnosis of dogs experimentally and naturally infected with Leishmania chagasi, in Brasil
19. Clinical and parasitological aspects of canine visceral leishmaniasis
20. Controle da leishmaniose visceral canina e humana em Montes Claros, Minas Gerais, Brasil
21. Les Exames de Laboratoire dans la leishmaniose canine
22. Studies on canine leishmaniasis control. 2. Effectivenees of control measures against canine leishmaniasis in the Isle of Elba, Italy
23. Decreased sensitivy to meglumine antimoniate (Glucantime®) of L. infantum isolated from dogs after several courses of drug treatment
24. Recomendations for treating leishmaniosis with Sodium stibogluconate (Pentostam) and review of pertinent clinical studies
25. Visceral leishmaniasis in the German shepherd dog. II. Pathology
26. Old world canine leishmaniasis
27. Use of allopurinol to treat visceral leishmaniosis in a dog
28. Allopurinol in the treatment of canine visceral leishmaniasis
29. Calazar na zona do Rio Doce - Minas Gerais. Resultados de medidas profiláticas
30. Studies on canine leishmaniasis control. I. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment
31. Immunological and histological study of T - and B - lymphocyte activity in canine visceral leishmaniosis
32. Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, parasitological, therapeutical and epidemiological findings (1977-1983)
33. A field trial of a vaccine against American dermal leishmaniasis
34. Combined immunotherapy and chemotherapy in canine visceral leishmaniasis preliminary findings
35. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs
36. Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis
37. Nouvelles acquisitions sur le Kala-azar : Cultures inoculations au chien, étiologi
38. Cellular and humoral immune response in dogs experimentally and naturally infected with Leishmania infantum
39. Zur leishmaniasos des hundes. Infektionsverlauf, diagnose um therapieversuche nach exp. Infection von beagles mit leishmania donovani (st. Kalkutta)
40. Canine leishmaniasis. A review based on 95 cases in the Netherlands
41. Leishmaniasis
42. Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog
43. Visceral leishmaniasis in a dog : Clinical, hematological and pathological observations
44. Leishmaniose visceral ou calazar : Aspectos epidemiológicos e de controle
45. Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin)